AXL and glioblastoma: This suggests an onco-dependency model for targeting the GBM kinome, wherein GBMs require signaling from Met, FGFR, Axl, and other kinases to sustain survival and metabolism, even as these kinases are intrinsically affected by oncogenic driver events.